ArticleCureus2025
Adult-Onset Neurological Deterioration in Dravet Syndrome Associated With a Novel SCN1A Missense Variant (p.Gly1371Asp): A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a 26-year-old woman with genetically confirmed Dravet syndrome (DS) who experienced atypical neurological deterioration in early adulthood, despite a previously stable clinical course. Her early history met the classical DS criteria, with the onset of febrile and afebrile seizures in infancy, followed by myoclonic, focal, and absence seizures, as well as developmental delay. Beginning at age 20, however, she developed new symptoms, including progressive tremor, postural instability, frequent gelastic-like seizures, and dysphagia severe enough to require temporary nasogastric feeding. Neuroimaging revealed basal ganglia and thalamic calcifications that had not been present in childhood. Mitochondrial evaluation demonstrated a mild reduction in oxygen consumption, despite normal enzyme activity. Genetic analysis, performed for the first time in adulthood, identified a previously unreported de novo missense variant in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.